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Role of membrane microdomains in PTH-mediated down-
regulation of NaPi-IIa in opossum kidney cells.
Background. Parathyroid hormone (PTH) rapidly down-
regulates type IIa sodium-dependent phosphate transporter
(NaPi-IIa) via an endocytic pathway. Since the relationship be-
tween PTH signaling and NaPi-IIa endocytosis has not been
explored, we investigated the role of membrane microdomains
in this process.
Methods. We examined the submembrane localization of
NaPi-IIa in opossum kidney (OK-N2) cells that stably expressed
human NaPi-IIa, and searched for a PTH-induced specific phos-
phorylating substrate on their membrane microdomains by im-
munoblotting with specific antibody against phospho substrates
of protein kinases.
Results. We found that NaPi-IIa was primarily localized in
low-density membrane (LDM) domains of the plasma mem-
brane; PTH reduced the levels of immunoreactive NaPi-IIa in
these domains. Furthermore, PTH activated both protein ki-
nase A (PKA) and protein kinase Ca (PKCa) and increased
the phosphorylation of 250 kD and 80 kD substrates; this latter
substrate was identified as ezrin, which a member of the ezrin-
radixin-moesin (ERM) protein family. In response to PTH,
ezrin was phosphorylated by both PKA and PKC. Dominant
negative ezrin blocked the reduction in NaPi-IIa expression in
the LDM domains that was induced by PTH.
Conclusion. These data suggest that NaPi-IIa and PTH-
induced phosphorylated proteins that include ezrin are
compartmentalized in LDM microdomains. This compartmen-
talization may play an important role in the down-regulation of
NaPi-IIa via endocytosis.
Serum inorganic phosphate (Pi) homeostasis is main-
tained by Pi reabsorption that is regulated by a sodium-
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dependent Pi transport system in the kidney [1, 2]. Type
IIa sodium-dependent Pi transporter (NaPi-IIa) medi-
ates most of the Pi reabsorption in the kidney and is
tightly regulated by various Pi-regulating hormones and
dietary phosphate intake [1–3].
Parathyroid hormone (PTH) is an important regula-
tor of Pi reabsorption in renal proximal tubules [1–3]
and was shown to rapidly reduce their NaPi-IIa activity
by stimulating apical endocytosis [4]. Down-regulation
of NaPi-IIa was reported to be mediated by protein ki-
nase A (PKA) and/or protein kinase C (PKC) activation
in these cells [1, 2, 5]. However, the exact mechanism by
which PTH mediates NaPi-IIa endocytosis is still unclear.
It has been suggested that membrane microdomains
such as lipid rafts and caveolae play a role in the down-
regulation of NaPi-IIa, since changes in the lipid com-
position (cholesterol/glycosphingolipids) of brush border
membranes was shown to modulate NaPi-IIa transport
activity [6]. Lipid rafts and caveolae are membrane mi-
crodomains that are enriched for cholesterol and sph-
ingolipids [7, 8] and are characterized as low-density
membrane (LDM) or Triton X-100 insoluble membrane
domains. Compartmentalization of certain signal trans-
duction molecules into these microdomains was shown
to play a role in the regulation of microdomain-mediated
membrane trafficking [7, 8]. As an example of this, the
presence of PKA and PKCa in caveolae was shown to
be important for the regulation of caveolae-dependent
endocytosis [9–11].
We hypothesized that in addition to NaPi-IIa, the PTH
receptor and its signal transducing molecules, including
PKA and PKC, as well as their substrates might simi-
larly be localized in membrane microdomains where they
play a role in the endocytosis-mediated down-regulation
of NaPi-IIa. Our data showed that NaPi-IIa and PTH-
mediated signal transduction molecules are localized in
LDM domains, and that PTH can increase the PKA- and
PKC-mediated phosphorylation of specific substrates in
these domains that mediate the down-regulation of NaPi-
IIa.
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METHODS
Antibodies
The anti-NaPi-2 polyclonal antibody that we used in
this study was one that was previously generated in our
laboratory [13]. Anti-FLAG monoclonal antibody was
purchased from Sigma Aldrich Japan (Tokyo, Japan).
Anti-myc-tag polyclonal antibody was purchased from
Upstate Biotechnology Inc (Lake Placid, NY, USA)
while the anticaveolin polyclonal antibody, antitransfer-
rin receptor monoclonal antibody, anti-PKA (a catalytic
subunit) monoclonal antibodies, and anti-PKCa mon-
oclonal antibodies were purchased from BD Pharmin-
gen (San Diego, CA, USA). The antiphospho-(serine)
PKC substrate polyclonal antibody and anti-phospho-
(serine/threonine) PKA substrate polyclonal antibodies
were purchased from Cell Signaling Technology, Inc.
(Beverly, MA, USA). Antiopossum PTH receptor mon-
oclonal antibody [opossum kidney-1 (OK-1)] was pur-
chased from Covance (Berkeley, CA, USA). Antiezrin
antibody was purchased from Zymed (South San
Francisco, CA, USA), and antiphospho ezrin (Thr567)
antibody from Chemicon (Temecula, CA, USA). For
the Western blot analyses, horseradish peroxidase–
conjugated antimouse or antirabbit IgG (Bio-Rad Japan,
Tokyo, Japan) was used as the secondary antibody.
Alexa555-conjugated goat antimouse IgG (Molecular
Probe, Eugene, OR, USA) was used for immunofluores-
cence analysis.
Plasmid construction
Human NaPi-IIa (NaPi-3) cDNA [14] was inserted
into the polycytomegalovirus (pCMV)-Tag2 vector
(Stratagene, La Jolla, CA, USA) at the BglII-XhoI site.
A cDNA fragment containing the human NaPi-IIa gene
and the eptitope tag (FLAG tag) was excised by restric-
tion endonucleases HindII, and inserted into the pIRES-
neo2 vector (Clonetech, Palo Alto, CA, USA) at the Eco
RV site (hereafter, pIRES-NaPi-IIa-FLAG).
Cell culture, transfection, and establishment
of stable cell lines
OK-P cells were kindly provided by Dr. Amemiya
(Jichi Medical School, Tochigi, Japan). The antirat NaPi-
IIa antibody (anti-NaPi-2 polyclonal antibody) devel-
oped in our previous study [13] reacts with human and
rat NaPi-IIa but not with endogenous opossum NaPi-IIa
in OK-P cells. The cells were maintained in plastic culture
dishes in Dulbecco’s modified Eagle’s medium (DMEM)
(LifeTechnologies, Gaithersburg, MD, USA) containing
25 mmol/L Hepes, 4000 mg/mL glucose, 1 mmol/L sodium
pyruvate, 50 lg/mL penicillin, 50 IU/mL streptomycin,
and 10% (vol/vol) fetal bovine serum (FBS) (Sigma-
Aldrich Japan, Tokyo, Japan) at 37◦C in a humidified
atmosphere of 5% CO2. Transfection was carried out
using Lipofectamine-plus (LifeTechnologies). To select
stable cell lines expressing human NaPi-IIa with FLAG
tag, pIRES-NaPi-IIa-FLAG was transfected into OK-P
cells, after which they were cultured in the presence of
2000 lg/mL of G418 for 10 days [15]. Following G418 se-
lection, the cells were subjected to subcloning by limited
dilution. Four cell lines (OK-N1 to OK-N4) were gen-
erated, and the response of each to PTH was character-
ized. The OK-N2 cell line expressed a moderate amount
of human NaPi-IIa and it was this cell line that was used
in our experiments. Cells were used within eight passages
of their establishment as a cell line.
Treatment with PTH and other chemicals
OK-N2 cells were seeded into 100 mm culture dishes
in the above media (maintenance media) that was sup-
plemented with 2000 lg/mL of G418, and were grown
to subconfluency. The cells were preincubated in work-
ing media [maintenance medium containing 0.1% bovine
serum albumin (BSA) instead of FBS] for 12 hours, af-
ter which they were treated with 10−7 mol/L PTH (1-34
fragment) (kindly provided from Asahi Kasei Pharma,
Tokyo, Japan) at 37◦C for either 0, 15, 30, or 60 minutes. In
some cultures, chlorpromazine (1 lmol/L), an inhibitor of
clathrin-dependent endocytosis, 3-methyl-b-cyclodextrin
(0.5 mmol/L), an inhibitor of LDM domains that acts
by chelating cholesterol, cytochalasin D (0.5 lmol/L),
a facilitator of actin depolymerization, or nocodazole
(1 lmol/L), a facilitator of microtubular depolymeriza-
tion was added for 5 minutes before the cells were
treated with PTH for 30 minutes. Go¨6976 (10 lmol/L)
(Calbiochem, San Diego, CA, USA), a specific inhibitor
of PKC, or H-89 (100 lmol/L) (Calbiochem), a specific in-
hibitor of PKA was added to other cultures for 5 minutes
before cells were treated with PTH for 20 minutes.
Pi uptake
Pi uptake was measured in OK-N2 cells grown to con-
fluency in 24-well plastic plates as previously described
[15]. Transport rates were expressed as pmol Pi per 104
cells per minute.
Cell fractionation
The detergent-free caveolae isolation method was used
for cell fractionation [16], with slight modifications as
described previously [9]. All experiments were carried
out at 4◦C. Cells were homogenized in ice-cold buffer
A [0.25 mol/L sucrose, 1 mmol/L ethylenediaminete-
traacetic acid (EDTA), and 20 mmol/L tricine, pH 7.8]
with a dounce homogenizer. The homogenate was then
centrifuged at 1000g for 10 minutes and the supernatant
extracted and designated as the postnuclear supernatant
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fraction (PNS). This fraction was subjected to gradient
centrifugation in a 30% percoll solution, prepared in
buffer A, at 84,000g for 30 minutes to obtain plasma mem-
branes. Sonicated plasma membranes were subjected
to a 10% to 20% OptiPrep (LifeTechnologies) gradi-
ent centrifugation (OptiPrep 1) at 52,000g for 90 min-
utes, after which the fractions were either sequentially
(1 mL/fraction) or collectively (the top 5 mL comprising
gradient fractions 1 to 5) harvested. The former were sub-
jected to Western blot analysis and protein determination
while the latter were subjected to 5%/30% OptiPrep gra-
dient centrifugation (hereafter referred to as OptiPrep
2). The opaque band located just above the 5% inter-
face was collected and designated as the LDM domains.
Pooled fractions 6 to 10 from OptiPrep 1 were designated
as the high-density membrane (HDM) domains.
Electrophoresis and Western blots
Samples were separated using 7% to 15% linear-
gradient sodium dodecyl sulfate (SDS)-polyacrylamide
gels and were transferred to a polyvinlydine diflu-
oride (PVDF) membrane (Immobilon-P) (Millipore
Japan, Tokyo, Japan) which was then incubated with
primary antibodies for 1h at room temperature. Af-
ter washing out the unbound antibodies, the mem-
brane was incubated with the appropriate horseradish
peroxidase–conjugated antimouse or antirabbit IgG for
1 hour at room temperature. Immunoreactive bands were
visualized using enhanced chemiluminescence (ECL)
(Amersham-Pharmacia Biotech Japan, Tokyo, Japan)
and were analyzed with an LAS-1000 lumino-image ana-
lyzer (Fujifilm, Tokyo, Japan); densitometric analysis was
also carried out.
Immunocytochemical analysis
OK-N2 cells that were grown on plastic coverslips were
incubated with 100 lg/mL of Alexa488-labeled cholera
toxin B subunit (CTB) (Molecular Probe) at 4◦C for
30 minutes before fixation, after which the cells were
fixed for 30 minutes with 3% (wt/vol) paraformaldehyde
in phosphate-buffered saline (PBS). The cells were then
permeabilized with 0.1% Triton X-100 in PBS for 10 min-
utes on ice. After blocking with 0.8% BSA in PBS for
1 hour, the cells were incubated with anti-FLAG tag mon-
oclonal antibody for 1 hour after which they were washed
and labeled with Alexa555-labeled antimouse IgG. The
cells were then washed and mounted on glass slides with
Aqua/poly mount (PolyScience, Niles, IL, USA). Slides
were analyzed and photographed using a Leica Confo-
cal Microscope (TCS-SL) (Leica Microsystems GmbH,
Mannheim, Germany) in the sequential mode. The x and
y plane images (512 × 512 pixels per image) were ob-
tained in the x, y, and z scan mode, and 18 z section im-
ages were taken. The top 1 to 4 z section images or bottom
14 to 18 z section images were projected onto one x and
y plane image from top to bottom. X and z plane and
y and z plane images were obtained from stacked 18 z
section images. Foci where CTB or NaPi-IIa was stained
and where their staining overlapped were counted in 12
images from four independent experiments. The coinci-
dence ratio was calculated using following equation: ra-
tio (%) = (the number of coincident foci)/(the number
of NaPi-IIa foci) × 100.
Determination of protein concentration
Protein concentrations were determined using the Bio-
Rad Bradford Assay (Bio-Rad Japan, Tokyo, Japan) with
a BSA standard.
Cyclic adenosine monophosphate (cAMP) assay
and cholesterol uptake assay
cAMP concentration was determined using a cAMP
Assay Kit (Amersham Pharmacia Biotech). Cholesterol
uptake was assessed as described previously [17] using
DiI-low-density lipoprotein (LDL) (Biomedical Tech-
nologies, Stoughton, MA, USA).
Amino acid sequence analysis
Amino acid sequence analysis was carried out by the
APRO Science Company (Tokushima, Japan). The 80
kD band that was separated by SDS-polyacrylamide gel
electrophoresis (PAGE) was subjected to “in gel” diges-
tion with lysylendopeptidase and the resulting peptides
were separated by reverse-phase high-performance liq-
uid chromatography (HPLC) [18]. Amino acid sequence
analysis of the peptides was carried out using a Procise
494cLC protein sequencer (Applied Biosystems Japan,
Tokyo, Japan).
Immunoprecipitation of ezrin
Ezrin was immunoprecipitated from LDM domains
that were obtained from Opti-Prep 2 cells that were
incubated in the presence or absence of 10−7 mol/L
PTH for 20 minutes. LDM domains were precipitated
by ultracentrifugation at 300,000 × g for 1 hour and
solubilized with TETN150/OG (25 mmol/L Tris-HCl,
pH 7.5, 5 mmol/L EDTA, 150 mmol/L NaCl, 1% Tri-
ton X-100, and 60 mmol/L n-octyl-b-D-glucopyranoside)
on ice. The solubilized samples were incubated with
antiezrin monoclonal antibodies at 4◦C overnight, af-
ter which the immunocomplexes were precipitated us-
ing protein A sepharose CL-4B that was precoated with
BSA. After washing out the unbound proteins 4 times
with TETN250 (25 mmol/L Tris-HCl, pH 7.5, 5 mmol/L
EDTA, 250 mmol/L NaCl, and 1% Triton X-100), the pre-
cipitates were suspended in 2 × SDS sample buffer and
subjected to Western blotting using antiezrin monoclonal
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antibody, antiphospho (serine/threonine) PKA substrate
polyclonal antibody, or antiphospho (serine) PKC sub-
strate polyclonal antibody, as described above.
Cloning and transient expression of N-terminal half of
ezrin (dominant-negative ezrin)
The N-terminal half of ezrin cDNA was generated
from the human colon cancer cell line, Caco-2 by reverse
transcription-polymerase chain reaction (RT-PCR) using
the following primers that contained their restriction
enzyme cleavage site either at XbaI for sense or HindIII
for antisense-sense 5′-GCTCTAGACCGAAAATG
CCGAAACCAATC-3′ (corresponding to −6 to +15,
A for translation initiation site is +1), antisense 5′-
CCCAAGCTTCTCCCGGGCCTGG GCCTTCAT-3′
(+913 to +933). Amplified cDNA fragments were
digested with XbaI and HindIII and subcloned into
the pcDNA 3.1 (−) myc-His A vector (Invitrogen),
which was transiently transfected into OK-N2 cells
with Lipofectamine-plus. Transfection efficiency was
estimated to be more than 60% using a green fluores-
cence protein (GFP) expression vector. Two days after
transfection, the cells were treated with 10−7 mol/L PTH
for 30 minutes after which they were subjected to LDM
domain preparation. The myc-tagged dominant-negative
ezrin was detected by anti-myc-tag polyclonal antibodies.
Statistical analysis
Data are presented as the means ± SEM. Statistical
significance (P < 0.05) between groups was determined
by analysis of variance (ANOVA) followed by post hoc
testing using Fisher’s protected least significant difference
(PLSD) procedure for multiple comparisons.
RESULTS
We confirmed that Pi transport in OK-N2 cells was
approximately 2.5-fold greater than that seen in parental
OK-P cells (4.93 ± 0.17 vs. 1.91 ± 0.29 pmol/min/104 cells,
respectively), and that treatment with 10−7 mol/L PTH
for 30 minutes reduced Pi transport activity in OK-N2
cells by about 50% of untreated OK-N2 cells (2.63 ±
0.087 pmol/min/104 cells) (P < 0.01). These data validated
the use of this cell line for the study of PTH regulation of
NaPi-IIa.
Biochemical and immunocytochemical analysis
of the localization of NaPi-IIa
To determine the location of NaPi-IIa in OK-N2 cells,
purified plasma membranes were subjected to OptiPrep
gradient centrifugation (OptiPrep 1). Western blots of
each fraction (total protein) from the OptiPrep 1 gradi-
ents showed that most of the NaPi-IIa was localized in
the LDM fractions as same as caveolin (Fig. 1A) (NaPi-
IIa, lanes 1 to 5). On the other hand, transferrin receptor
that is located in clathrin-coated pits was detected in the
heavier fractions (lanes 6 to 10).
We also examined the location of NaPi-IIa in OK-
N2 cells by immunofluorescence using the localization of
CTB as a reference control. CTB, a well-characterized
membrane microdomain marker protein that binds to
GM1 ganglioside, was strongly localized to the apical
plasma membrane (Fig. 1C). FLAG-tagged NaPi-IIa
was similarly localized to the apical plasma membrane
(Fig. 1D), in a pattern that was similar to that of CTB
(Fig. 1E). We found that 77.5 ± 5.23% of the NaPi-IIa
foci colocalized with CTB. We also found that most of
the caveolin was localized in the basolateral membrane
and was not obviously colocalized with NaPi-IIa (Fig. 2).
Effects of PTH on the localization of NaPi-IIa
in LDM domains
We next examined whether PTH influenced the expres-
sion of NaPi-IIa in the low-density fractions in OptiPrep
1. Following treatment with 10−7 mol/L PTH for 30 min-
utes, the OptiPrep 1 fraction showed reduced levels of
NaPi-IIa in the low-density fractions (Fig. 1B, lanes 1 to
5) compared to controls (Fig. 1A). PTH did not affect the
localization of either the transferrin receptor or caveolin.
As shown in Figure 3A, a decrease in NaPi-IIa in
plasma membranes and LDM domains in OptiPrep2 was
observed in response to a 15-minute to 60-minute incuba-
tion with PTH. Densitometric analysis revealed that 50%
of the NaPi-IIa disappeared from the LDM domains after
15 minutes, and 80% had decreased by 60 minutes; these
results were statistically significant (Fig. 3B). Degrada-
tion of NaPi-IIa by PTH was not observed up through
60 minutes (PNS in Fig. 3), but did occur by 2 hours (data
not shown).
Effects of 3-methyl-b-cyclodextrin, chlorpromazine,
cytocharasin D, and nocodazole on the reduction in
NaPi-IIa in the LDM domains by PTH
We examined the effects of the following four in-
hibitors on the down-regulation of NaPi-IIa: 3-methyl-
b-cyclodextrin, chlorpromazine, cytochalasin D, and
nocodazole. PTH significantly reduced the amount of
NaPi-IIa in the LDM domains of OK-N2 cells (Fig. 4A
and B). PTH also significantly inhibited Pi uptake ac-
tivity (Fig. 4C). However, 3-methyl-b-cyclodextrin and
cytochalasin D strongly inhibited PTH’s influence on
NaPi-IIa translocation (Fig. 4, lanes 3 and 5); 3-methyl-b-
cyclodextrin did not affect PTH-mediated cAMP produc-
tion (Fig. 5A). Chlorpromazine and nocodazole slightly
inhibited the actions of PTH (Fig. 4, lanes 4 and 6). We
confirmed that chlorpromazine inhibited DiI-LDL up-
take in OK-N2 cells at the concentration used (1 lmol/L)
(Fig. 5B). All four inhibitors had no effect on either the
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Fig. 1. Biochemical and immunocytochemical sub-membrane localiza-
tion of sodium-dependent phosphate transporter (NaPi-IIa). (A) NaPi-
IIa and caveolin in the low-density membrane (LDM) fractions derived
from opossum kidney (OK-N2) cells were fractioned by OptiPrep 1 gra-
dient centrifugation. Tf-R is antitransferrin receptor monoclonal anti-
body. (B) Effects of parathyroid hormone (PTH) on the localization
of NaPi-IIa fractioned by OptiPrep 1 gradient centrifugation. OK-N2
cells were incubated in the presence of 10−7 mol/L parathyroid hormone
(PTH) for 30 minutes. OK-N2 cells were immunocytochemically stained
with cholera toxin B subunit (CTB) (C) or anti-FLAG-tag monoclonal
antibody (D). (E) A merger of the images (C and D). Yellow dots
indicate colocalization. Images were taken by confocal laser-scanning
microscopy with a 63× oil immersion objective lens. The lower and right
side panels show xy cross-sections (xz and yz planes) that were taken
at the intersecting white lines (scale bar, 4 lm). The data presented are
from four independent experiments.
Caveolin FLAG Merge
xy
(apical)
xy
(basal)
xz
Fig. 2. Localization of caveolin and sodium-dependent phosphate
transporter (NaPi-IIa) in opossum kidney (OK-N2) cells. OK-N2 cells
were stained with anti-caveolin polyclonal antibody and anti-FLAG-
tag monoclonal antibodies. Upper panels show the top xy sections, the
middle panels show the bottom xy sections, and the bottom panels show
the xz cross-sections. The data presented are from four independent ex-
periments (scale bar, 4 lm).
amount of NaPi-IIa in the LDM domains or Pi uptake
per se (Fig. 4, lanes 7 through 11).
Activation of PKCa and PKA in LDM domains by PTH
As shown in Figure 6A, the PTH receptor was lo-
calized in the LDM domains of OK-N2 cells. PTH and
8-bromo-cAMP reduced the amount of NaPi-IIa in the
LDM domains (Fig. 6B and C) but increased the phos-
phorylation of PKA substrates at 80 kD and 250 kD in the
LDM domains and at 175, 120, 80, and 65 kD in the PNS
and cytosol, but not in the HDM domains (Fig. 6C). On
the other hand, the amount of PKA in each fraction did
not change as a result of PTH or 8-bromo-cAMP stim-
ulation (Fig. 6B). Interestingly, PKCa levels increased
in the LDM domains and decreased in the cytosol after
PTH or phorbol 12,13-myristic acetate (PMA) treatment
(Fig. 7A). The phosphorylation of PKC substrates was
significantly increased at 250, 190, 110, and 80 kD in the
LDM domains but not in the cytosol or HDM domains
(Fig. 7B).
Amino acid sequence analysis and functional analysis of
the 80 kD substrate
To identify the substrate at 80 kD, we performed amino
acid sequence analysis on the 80 kD protein by “in-gel”
digestion with lysylendopeptidase. We identified the pep-
tide “IALLEEARRRKE” as a part of the candidate sub-
strate. Homology search results showed that the peptide
was identical to rat, mouse, and human ezrin. This com-
pound fractionated into the LDM domains in a manner
comparable to NaPi-IIa and caveolin (Fig. 8A), though
PTH did not affect the localization of ezrin as it did NaPi-
IIa (Fig. 8B).
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Fig. 3. Time-dependent effects of parathyroid hormone (PTH) on
sodium-dependent phosphate transporter (NaPi-IIa) localization in the
low-density membrane (LDM) domains. Opossum kidney (OK-N2)
cells were incubated in the presence of 10−7 mol/L PTH for the in-
dicated period of time. (A) Western blot analysis of time-dependent
effects of PTH on localization of NaPi-IIa and caveolin in each cell frac-
tion. PM is plasma membrane, PNS is postnuclear supernatant (time 0,
15, 30, and 60 minutes). The data presented are from three independent
experiments. (B) Densitometric analysis of NaPi-IIa in (A). The data
presented are from three independent experiments. All values are ex-
pressed as the mean ± SEM of triplicate smaples. The relative amount
of NaPi-IIa at time 0 was 1. ∗P < 0.01; ∗∗P < 0.05 vs. time 0.
In order to determine whether ezrin was phosphory-
lated in response to PTH, we examined phosphorylation
of its Thr567 residue. As shown in Fig. 8C, PTH reduced
the amount of NaPi-IIa in the LDM domains (Fig. 8C,
lane 2). PTH-dependent NaPi-IIa translocation was in-
hibited not only by 3-methyl-b-cyclodextrin (Fig. 8C, lane
3) but also Go¨6976 (Fig. 8C, lane 4), a specific inhibitor of
PKC, and H-89 (Fig. 8C, lane 5), a specific PKA inhibitor.
Both Go¨6976 and H-89 inhibited the phosphorylation of
ezrin at Thr567 (Fig. 8C, lanes 4 and 5); this phospho-
rylation was not increased by PTH (Fig. 8C, lane 2). In
consideration of the fact that PTH might enhance phos-
phorylation at sites other than serine/threonin residues,
we immunoprecipitated ezrin from the LDM domains
and then determined its degree of phosphorylation us-
ing antiphospho-(serine) PKC polyclonal antibodies and
anti-phosho-(serine/threonine) PKA polyclonal antibod-
ies. As shown in Figure 8D, both serine-phosphorylation
by PKC and serine/threonine-phosphorylation by PKA
was markedly increased after PTH treatment (Fig. 8D,
lane 2); this phosphorylation was inhibited by specific in-
hibitors of PKC and PKA (Fig. 8D, lanes 4 and 5). On
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Fig. 4. Effects of 3-methyl-b-cyclodextrin, chlorpromazine, cytocha-
lasin D, and nocodazole on the reduction of sodium-dependent phos-
phate transporter (NaPi-IIa) in the low-density membrane (LDM)
domains (A and B) and on Pi uptake (C) in the presence and ab-
sence of parathyroid hormone (PTH). Opossum kidney (OK-N2) cells
were preincubated with 0.5 mmol/L 3-methyl-b-cyclodextrin (3MC), 1
lmol/L chlorpromazine (CPZ), 0.5 lmol/L cytochalasin D (CytD), or
1 lmol/L nocodazole (Noco) for 5minutes, after which they were in-
cubated with (lanes 2 to 6) or without (lane 1 and lanes 7 to11) PTH.
(A) LDM domains were prepared and separated by gel electrophoresis
(20 lg/lane) and were immunoblotted with anti-NaPi-II polyclonal an-
tibody or anti-caveolin polyclonal antibody. (B) Densitometric analysis
of the amount of NaPi-IIa. Values are the means ± SEM of triplicate
samples. Relative NaPi-IIa amount at time 0 was 1. ∗P < 0.01 vs. lane 1;
∗∗P < 0.05 vs. lane 1 and P < 0.01 vs. lane 2. (C) Estimation of Pi uptake
activity. Values are the means ± SEM of triplicate samples. ∗P < 0.01
vs. lane 1; ∗∗P < 0.01 vs. lane 1 and P < 0.05 vs. lane 2, respectively.
the other hand, 3-methyl-b-cyclodextrin did not affect
the phosphorylation of ezrin (Fig. 8D, lane 3).
To investigate the role of ezrin in the PTH-mediated re-
duction of NaPi-IIa in the LDM domains, we transiently
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Fig. 5. Effects of 3-methyl-b-cyclodextrin on cyclic adenosine
monophosphate (cAMP) production (A) and chlorpromazine on DiI-
low-density lipoprotein (LDL) uptake (B) in response to parathyroid
hormone (PTH) in opossum kidney (OK-N2) cells. (A) OK-N2 cells
were treated with PTH (10−8 to 10−6 mol/L) in the presence or ab-
sence of 0.5 mmol/L of 3-methyl-b-cyclodextrin for 15 minutes, after
which the amount of cAMP in these cells was determined. Values are
expressed as the mean ± SEM of triplicate samples. (B) OK-N2 cells
were incubated with or without 1 lmol/L of chloropromazine for 5 min-
utes before LDL uptake, after which they were incubated with 20 lg/mL
DiI-LDL at 37◦C for 30 minutes in the absence (control) or presence of
1 lmol/L chlorpromazine. The cells were fixed in 3% paraformaldehyde
and processed for microscopy. Internalized DiI-LDL appeared as large
vesicles scattered throughout the cell.
expressed the N-terminal region of ezrin that was a
dominant-negative ezrin, and found that such manipu-
lation inhibited this PTH effect (Fig. 8E, lanes 3 and 4).
Furthermore, we also found that dominant-negative ezrin
reduced the amount of NaPi-IIa and endogenous ezrin
(ezrin-WT) in the LDM domains (Fig. 8E, lane 1 vs. lane
3). Both NaPi-IIa and ezrin-WT expression level in the
PNS had never changed by such manipulation (data not
shown).
DISCUSSION
Our results suggest that NaPi-IIa as well as PTH-R,
PKA, and PKC and their substrates are localized in the
LDM domains of OK-N2 cells that corresponds to the lo-
cation of lipid rafts and/or caveolae. The apical membrane
of epithelial cells is enriched for cholesterol and sphin-
golipids, and this region also contains lipid rafts and cave-
olae [19]. In this study, caveolin which is a marker protein
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Fig. 6. Localization of parathyroid hormone (PTH) signaling
molecules. (A) Submembrane localization of the PTH receptor. Opos-
sum kidney (OK-N2 cells were partitioned in the indicated fractions and
PTH receptor and caveolin were detected by western blotting. (B and C)
Effects of PTH and 8-bromo-cyclic adenosine monophosphate (cAMP)
on the subcellular localization of sodium-dependent phosphate trans-
porter (pNaPi-IIa), protein kinase A (PKA), and caveolin (B) and on
PKA substrate phosphorylation (C). OK-N2 cells were treated as fol-
lows: control (lanes 1, 4, and 7), 10−7 mol/L PTH (lanes 2, 5, and 8) for
15 minutes, or 200 nM 8-bromo-cAMP (lanes 3, 6, and 9) for 15 minutes.
The bands indicated by the arrowheads are significantly greater than the
control. The data presented are from three independent experiments.
PNS is post nuclear supernatant.
for caveolae was localized in the basolateral membrane of
our renal proximal tubule cells, a finding that confirmed a
previous report [20]; caveolin and most of the cell’s NaPi-
IIa was sublocalized in these cell’s LDM domains. The
fractioned LDM domains that we used contained mem-
brane microdomains derived from both the apical and ba-
solateral membrane, suggesting that the caveolin that we
identified was likely to have been derived from the baso-
lateral membrane. To exclude basolateral membrane con-
tamination in our study, we investigated whether caveolin
and NaPi-IIa were cofractionated in the LDM domains
from apical membranes isolated from OK-N2 cells and
the rat renal cortex, resulting that the cofractionation was
observed (unpublished observations). Our data suggest
that NaPi-IIa is localized in membrane microdomains
that are biochemically similar to caveolae. Simons and
Toomre [21] described caveolae as morphologically de-
fined cell surface invaginations (containing caveolin) that
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Fig. 7. Effects of parathyroid hormone (PTH) and phorbo 12-
myristate 13-acetate (PMA) on the subcellular localization of sodium-
dependent phosphate transporter (NaPi-IIa), protein kinase C (PKCa),
and caveolin (A) as well as on PKC substrate phosphorylation (B).
Opossum kidney (OK-N2) cells were treated with 10−7 mol/L PTH or
200 nmol/L PMA for 15 minutes. Lanes 1, 4, and 7 were control, lanes
2, 5, and 8 were 10−7 mol/L PTH, and lanes 3, 6, and 9 were 200 nmol/L
PMA. The bands indicated by the arrowheads are significantly greater
than the control. The data presented are from three independent ex-
periments. PNS is post nuclear supernatant
were distinct from other membrane microdomains, even
though these microdomains sorted into the low-density
fractions due to their unique lipid composition. Our data
suggest that LDM domains that contain NaPi-IIa should
be classified as lipid rafts or some other membrane mi-
crodomains, rather than as caveolae. These observations
are in agreement with the recent findings of Inoue et al
[22] that NaPi-IIa partitioned in such a membrane mi-
crodomains in the rat kidney.
It is well known that, in response to PTH and other hor-
mones, NaPi-IIa can be internalized by endocytosis and
rapidly inhibit Pi reabsorption in renal proximal tubules
[1–4]. We demonstrated that PTH decreased the levels of
NaPi-IIa in the LDM domains of OK-N2 cells. We also
found that 3-methyl-b-cyclodextrin blocked this effect
and reduced PTH-induced Pi transport activity, though
this compound did not inhibit PTH-dependent cAMP
production or the phosphorylation of ezrin. Thus, methyl-
b-cyclodextrin may block PTH-induced endocytosis but
not the production of second messenger.
There are two possible mechanisms by which
NaPi-IIa endocytosis occurs. The first is by clathrin-
independent endocytosis that is mediated by the
membrane microdomains. The second is by clathrin-
dependent endocytosis. Traebert et al [23] demonstrated
by immunoelectron microscopy that NaPi-IIa could be
internalized by clathrin-coated pits. Our data, however,
revealed only a nominal effect of chlorpromazine, an
inhibitor of clathrin-coated pit formation on the down-
regulation of NaPi-IIa by PTH. Although the relationship
between clathrin-dependent endocytosis and clathrin-
independent endocytosis vis-a`-vis the down-regulation of
NaPi-IIa is unclear, PTH-induced reductions in NaPi-IIa
in the LDM domains could be the trigger of endocytosis
in OK-N2 cells. Another possibility is that lateral traffick-
ing of NaPi-IIa occurs between membrane microdomains
and clathrin-coated pits, though we found no evidence of
this.
Colocalization of NaPi-IIa in the LDM domains with
the PTH receptor and other signaling molecules is prob-
ably important for the normal functioning of PTH, since
many signaling molecules were reported to be compart-
mentalized in membrane microdomains; this compart-
mentalization was also found to be important for effective
signal transduction [8, 10]. We confirmed that the sig-
naling molecules PTH receptors, PKA, and PKC could
localize in the same microdomain as NaPi-IIa and at-
tempted to determine whether this microdomain also lo-
calized a specific phosphorylated substrate in response
to PTH. Mineo et al [9] and Smart, Ying, and Anderson
[24] showed that the compartmentalization of PKCa in
caveolae was essential for their invagination; they also
reported the localization of a 90 kD phosphorylatable
molecule in these caveolae. In our study, we showed that
both PKA and PKCa could be targeted to the LDM do-
mains and be activated by PTH. We also identified two
common substrates (80 and 250 kD) for both PKA and
PKC in the LDM domains of OK-N2 cells, which have
been implicated in NaPi-IIa inhibition.
We were able to identify the above, 80 kD molecule as
ezrin. Ezrin is a member of ERM protein family, and is
an 81 kD polypeptide that is rapidly phosphorylated at its
tyrosine residues in response to epidermal growth factor
[25]. It has also been shown that ezrin can be phosphory-
lated by both PKA [26] and PKCa [27]. Ezrin is generally
localized in the cytosol, but phosphorylated ezrin local-
izes beneath the brush border membrane in epithelial
cells and crosslinks the actin cytoskeleton to the plasma
membrane [28]. In that capacity, it is thought to play
a role in the regulation of cortical membrane structure
[28], cell motility [27], and the internalization of recep-
tor/transporters [29, 30]. Our data also showed that ezrin
can localize to the LDM domains along with NaPi-IIa and
that it is phosphorylated in response to PTH. Interest-
ingly, the target moiety in ezrin that was phosphorylated
in response to PTH was not threonine at 567, which is a
well-characterized phosphorylation site in the molecule
[31]. Recently, Zhao et al [32] showed that phosphoryla-
tion of ezrin at 567 was required for NHE3 recruitment
to the apical membrane. The C-terminal of ezrin con-
tains a binding site for F-actin (C-terminal 35 residues),
suggesting that the phosphorylation of Thr567 was im-
portant for its interaction with F-actin [31]. Tsukita and
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Fig. 8. Submembrane localization of ezrin and its role in the downregu-
lation of sodium-dependent phosphate transport (NaPi-IIa) by parathy-
roid hormone (PTH). (A and B) Opossum kidney (OK-N2) cells were
cultured in the presence or absence of 10−7 mol/L PTH for 20 minutes,
Yonemura [33] also concluded that the C-terminal phos-
phorylation of ezrin helped to maintain its activated form.
On the other hand, ezrin is known to have four potential
PKA phosphorylation sites (Thr11, Ser249, Thr332, and
Thr519) and seven PKC phosphorylation sites (Thr25,
Thr98, Ser148 or 149, Thr358, Thr425, and Thr567), as
confirmed using NetPhos 2.0. Our data suggest that PTH
does not affect the phosphorylation of ezrin at Thr567,
but increases its PKC-mediated phosphorylation at ser-
ine residues and PKA-mediated phosphorylation at ser-
ine/threonine residues. Specific inhibitors of PKA and
PKC inhibited these phosphorylations as well as the PTH-
induced reduction in NaPi-IIa. Thus, PTH may enhance
phosphorylation of ezrin at the above sites rather than at
Thr567, and these phosphorylations may be closely asso-
ciated with the PTH-mediated reductions in NaPi-IIa.
Interestingly, NaPi-IIa was shown to indirectly inter-
act with ezrin via NHERF-1 [also called ezrin binding
protein-50 (EBP-50)] [34], supporting the notion that this
protein may be an important intermediate in PTH ac-
tion [35]. However, a recent report suggested that while
NHERF-1 was important for the apical membrane tar-
geting and expression of NaPi-IIa protein, endocytosis of
NaPi-IIa in response to PTH/PKA/PKC did not require
NHERF-1 [36]. NHERF-1 was shown to interact not only
with transporters but also ion channels and G protein–
coupled receptors, and to play a role in the formation of
macromolecular complexes and signal transduction [37].
Mahon and Segre [38] reported that NHERF-1 interacted
with the PTH receptor, phospholipase C, and actin in OK
cells [38]. They also found that cytochalasin D disrupted
the apical colocalization of both NHERF-1 and the PTH
receptor, and inhibited PTH-mediated signaling [38]. In
our study, cytochalasin D but not nocodazole inhibited
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
after which they were subjected to OptiPrep gradient centrifugation
analysis in a manner similar to that described in Figures 1A and B.
(C) Effects of various inhibitors on PTH-dependent NaPi-IIa translo-
cation and on the phosphorylation of ezrin at Thr567. OK-N2 cells
were incubated in the absence (lane 1) or presence of 10−7 mol/L PTH
(lanes 2 to 5) for 20 minutes as well as either 3-methyl-b-cyclodextrin
(3MC) (lane 3), Go¨6976 (lane 4), or H-89 (lane 5). Low-density mem-
brane (LDM) domains were subjected to Western blot analysis using
anti-NaPi-IIa polyclonal antibodies, antiphospho ezrin (Thr567) mon-
oclonal antibodies, and anticaveolin polyclonal antibodies. (D) OK-N2
cells were treated as described (C), after which their LDM domains
was prepared and immunoprecipitated using antiezrin monoclonal an-
tibodies. The precipitants were subjected to Western blot analysis using
antiphospho-serine protein kinase C (PKC) substrate polyclonal anti-
body, antiphospho-serine/threonine protein kinase A (PKA) substrate
polyclonal antibody, and antiezrin monoclonal antibody. (E) Effect of
dominant-negative ezrin (ezrin-DN) on the PTH-induced reduction in
NaPi-IIa in the LDM fraction. Two days after either the mock or ezrin-
DN expression vector was transiently transfected into OK-N2 cells, the
cells were incubated in the presence or absence of 10−7 mol/L PTH
for 30 minutes. The levels of NaPi-IIa, endogenous ezrin (ezrin-WT),
ezrin-DN, and caveolin in the LDM domains were analyzed by Western
blotting. The data presented are from three independent experiments.
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the PTH-induced reduction in NaPi-IIa, suggesting that
cytoskeletal actin rather than microtubules were impor-
tant for the rapid down-regulation of NaPi-IIa by PTH.
Thus, ezrin may play an important role in the transmis-
sion of PTH-dependent cellular signals to actin that help
to effect endocytosis.
To investigate the role played by ezrin in the down-
regulation of NaPi-IIa by PTH, we transiently expressed
the N-terminal half of ezrin (dominant-negative ezrin) in
OK-N2 cells. This region contains the NHERF-1 bind-
ing site but not the actin binding site. Overexpression
of this region of the molecule was reported to have a
dominant-negative effect and to inhibit the morphogen-
esis of epithelial cells [39], bacterial entry into epithe-
lial cells [40], and estrogen-regulated endocytosis of LDL
[41]. Expression of dominant-negative ezrin resulted in
the inhibition of the PTH-mediated reduction in NaPi-
IIa in OK-N2 cells, suggesting that ezrin was necessary
for the down-regulation of NaPi-IIa by PTH. Addition-
ally, dominant-negative ezrin also interferred the target-
ing of NaPi-IIa into the LDM domains with inhibiting
the targeting of endogenous ezrin, thus, ezrin would be
important for targeting of NaPi-IIa to the membrane mi-
crodomains of plasma membrnane. Ezrin and NHERF-1
are likely to be important for the formation of the PTH
receptor/NaPi-IIa/actin macromolecular complex in the
microdomains in the apical membrane. Phosphorylated
ezrin may modulate the NaPi-IIa/NHERF-1/actin com-
plex, resulting in the eventual endocytosis of NaPi-IIa.
Membrane microdomains likely act as a platform for
the macromolecular NaPi-IIa complex, signal transduc-
tion molecules (PTH receptor, PKA, and PKC), as well
as cytoskeletal molecules. Ezrin is targeted to these mi-
crodomains and may play an important role in transform-
ing PTH-dependent cellular signals into endocytosis.
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